A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

In Vivo Forward Genetic Screen to Identify Novel Neuroprotective Genes in Drosophila melanogaster

9K views

⸱

DOI:

10.3791/59720

⸱

July 11th, 2019

 ,  ,  ,  ,  ,  ,  ,  ,  , 

Corresponding Authors: Stanislava Chtarbanova <schtarbanova@ua.edu>

In This Article

Summary

We present a protocol using a forward genetic approach to screen for mutants exhibiting neurodegeneration in Drosophila melanogaster. It incorporates a climbing assay, histology analysis, gene mapping and DNA sequencing to ultimately identify novel genes related to the process of neuroprotection.

Abstract

There is much to understand about the onset and progression of neurodegenerative diseases, including the underlying genes responsible. Forward genetic screening using chemical mutagens is a useful strategy for mapping mutant phenotypes to genes among Drosophila and other model organisms that share conserved cellular pathways with humans. If the mutated gene of interest is not lethal in early developmental stages of flies, a climbing assay can be conducted to screen for phenotypic indicators of decreased brain functioning, such as low climbing rates. Subsequently, secondary histological analysis of brain tissue can be performed in order to verify the neuroprotective function of the gene by scoring neurodegeneration phenotypes. Gene mapping strategies include meiotic and deficiency mapping that rely on these same assays can be followed by DNA sequencing to identify possible nucleotide changes in the gene of interest.

Introduction

Neurons are for the most part post-mitotic and incapable of dividing1,2. In most animals, neuroprotective mechanisms exist to maintain these cells throughout the organism's lifespan, especially at old age when neurons are most vulnerable to damage. Genes underlying these mechanisms can be identified in mutants exhibiting neurodegeneration, a phenotypic indicator for the loss of neuroprotection, using a forward genetic protocol. Forward genetic screens using chemical mutagens such as ethyl methanesulfonate (EMS) or N-ethyl-N-nitrosourea (ENU) are particularly useful due to the random point mutations they in....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Preparation and Aging of Flies

  1. Obtain or generate6 a collection of Drosophila mutants that will be used for the genetic screen. Here, ENU-mutagenized lines mapped to the second chromosome and balanced over CyO are used.
  2. Amplify experimental genotype lines in an incubator set at 25 °C, 12 h light/dark cycle on cornmeal-molasses medium.
  3. Collect around 20 homozygous progeny between 0-2 days of adult eclosion from each experimental genotype. Eliminate sex bias by consistently collecting either male or female flies.
  4. Age the flies on cornmeal-molasses medium as desired at 29 °C,....

Access restricted. Please log in or start a trial to view this content.

Results

In this aerticle, we present the steps used to identify the gene brain tumor (brat) as playing a role in maintenance of neuronal integrity (e.g., neuroprotection) in adult flies17; a methodology that can be used to identify genes involved in neuroprotection. We used a forward genetic approach (the strategy is outlined in Figure 1A) to screen through a collection of chemically mutagenized flies using a climbing assay (.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Forward genetic screens in Drosophila have been an effective approach to identify genes involved in different biological processes, including age-dependent neuroprotection5,23,24,25. Using this strategy, we were successful in identifying brat as a novel neuroprotective gene17.

One critical step in this protocol involves the p.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare no conflicts of interest.

Acknowledgements

We are particularly grateful to Dr. Barry Ganetzky, in who's lab the genetic screen was performed, allowing the identification and characterization of brat as a neuroprotective gene. We thank Dr. Steven Robinow for kindly providing the collection of ENU-mutagenized flies used in the genetic screen presented in this article. We thank the members of Ganetzky lab, Drs. Grace Boekhoff-Falk and David Wassarman for helpful discussions throughout the duration of this project, Ling Ling Ho and Bob Kreber for technical assistance, Dr. Aki Ikeda for the use of his microtome facility at the University of Wisconsin and Dr. Kim Lackey and the Optical Analysis Facility....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Major equipment
Fume hood for histology
Light MicroscopeNikonEclipe E100Preferred objective for imaging is 20x
Imaging softwareNikon
Microscope CameraNikon
Thermal cyclerEppendorf
Fly pushing and climbing assay
VWR® Drosophila Vial, NarrowVWR75813-160
VWR® General-Purpose Laboratory Labeling TapeVWR89097-912
Standard mouse pad
StereoscopeMoticModel SMZ-168
CO2 anesthesia station (Blowgun, foot valve, Ultimate Flypad)Genesee Scientific54-104, 59-121, 59-172Doesn’t iinclude CO2 tank
Fine-Tip BrushesSOLO HORTON BRUSHES, INC.
Drosophila IncubatorVWR89510-750
Gene mapping
CantonSBloomington Drosophila Stock Center9517
w1118Bloomington Drosophila Stock Center5905
yw Bloomington Drosophila Stock Center6599
Drosophila line used for recombination mappingBloomington Drosophila Stock Center3227Genotype: wg[Sp-1] J[1] L[2] Pin[1]/CyO, P{ry[+t7.2]=ftz/lacB}E3
CyO/sno[Sco] Bloomington Drosophila Stock Center2555Drosophila balancer line used for recombination mapping
Deficiency Kit for chromosome 2LBloomington Drosophila Stock CenterDK2LCook et al., 2012
Histology analysis
Ethanol, (100%)Thermo Fischer ScientificA4094
ChloroformThermo Fischer ScientificC298-500
Glacial Acetic AcidThermo Fischer ScientificA38-500
Fisherbrand™ Premium Microcentrifuge Tubes: 1.5 mLThermo Fischer Scientific05-408-129
Histochoice clearing agent 1xVWR Life Sciences97060-934
Harris HematoxylinVWR95057-858
EosinVWR95057-848
Thermo Scientific™ Richard-Allan Scientific™ Mounting MediumThermo Scientific™ 411222-110-610CyO/sna[Sco]
Unifrost Poly-L-Lysine microscope slides, 75 mm x 25 mm x 1 mm, EverMark Select PlusAzer Scientific
Fisherbrand™ Cover Glasses: RectanglesFisherbrand12-545MDimensions: 24 mm x 60 mm
Traceable timerVWR
Slide WarmerBarnstead Internationalmodel no. 26025
Slide tray and racksDWK Life SciencesRack to hold 20 slides
Fisherbrand™ General-Purpose Extra-Long ForcepsFisherbrand10-316A
Kimwipes™Kimberly-Clark™ Professional 
6 inch Puritan applicatorsHardwood Products Company, Guilford, Maine807-12
VWR® Razor BladesVWR55411-050
Tupperware or glass containers for histology liquids16 + 1 for running water
High Profile Coated Microtome BladesVWR95057-834
Corning™ Round Ice Bucket with Lid, 4 LCorning™
BeakerOr other container for ice water and cassettes
Tissue BathPrecision Scientific Company66630
MicrotomeLeica Biosystems
Molecular analysis
Wizard® SV Gel and PCR Clean-Up SystemPromegaA9282
Ex Taq DNA polymeraseTaKaRa5 U/μl
Invitrogen™ SYBR™ Safe™ DNA Gel Stain  Invitrogen™
UltraPure™ Agarose Invitrogen™
1 Kb Plus DNA Ladder Invitrogen™
ApE-A plasmid Editor softwareAvailable for free download
Statistical analysis
R software package
Further analysis
y[1] w[*]; wg[Sp-1]/CyO; Dr[1]/TM3, Sb[1]Bloomington Drosophila Stock Center59967

References

  1. Frade, J. M., Ovejero-Benito, M. C. Neuronal cell cycle: the neuron itself and its circumstances. Cell Cycle. 14 (5), 712-720 (2015).
  2. Aranda-Anzaldo, A. The post-mitotic state in neurons correlates with a stable nuclear higher-order structure.....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Climbing AssayHistological AnalysisDeficiency MappingDNA SequencingCarnoy's FixativeParaffin EmbeddingHematoxylin Staining